节点文献
食管静脉曲张出血内镜下硬化治疗的临床应用
The Clinical Application of Sclerosing Agent to Esophageal Varix Bleeding Under Endoscope
【摘要】 目的总结食管静脉曲张出血患者在内镜下采用改进静脉内注射法行硬化治疗的经验。方法对85例食管静脉曲张出血患者在内镜下采用改进静脉内注射法注射5%鱼肝油酸钠进行止血治疗。结果急诊内镜下硬化治疗55次,急诊止血成功53次,急诊止血成功率96.4%;非急诊内镜下硬化治疗176次;治疗结束后复查胃镜,静脉曲张消失44例,基本消失29例,消失和基本消失占85.9%。内镜下硬化治疗发生并发症9例(占10.6%);住院期间非内镜下硬化治疗发生并发症死亡5例(占5.9%)。治疗2周后复查胃镜42例(占49.4%)出现浅溃疡,经治疗后痊愈;治疗1个月后3例出现食道狭窄,经分次扩张后改善。结论在内镜下采用改进静脉内注射法注射5%鱼肝油酸钠是治疗食管静脉曲张出血的安全、有效、简便方法。
【Abstract】 Objective To summarize the experiences of the therapy for esophageal varix bleeding with improved intravenous sclerosing agent injection under endoscope. Methods Morrhuate sodium (concentration was 5%) was administered to 85 patients with esophageal varix bleeding via the above way.Results There were 55 times of urgent sclerosing agent therapy, 53 times (96.4%) of which were successful in the control of bleeding. Non-urgent therapy was given 176 times. After therapy, there were 44 patients whose varices wholly disappeared and 29 ones whose varices basically disappeared, which accounted for 85.9%. Five patients (5.9%) died of complications not relative to sclerosing agent therapy. According to the gastroscopic check done two weeks after therapy, 42 patients (49.4%) suffered from shallow ulcers that healed up by therapy. The conditions of the three patients who suffered from esophageal stricture one month after sclerosing therapy were improved by dilatation by stages.Conclusion It is safe, effective and convenient that improved intravenous morrhuate sodium injection is given under endoscope.
- 【文献出处】 临床军医杂志 ,Clinical Journal of Medical Officer , 编辑部邮箱 ,2005年02期
- 【分类号】R575.2
- 【被引频次】4
- 【下载频次】54